Drugs / rhARSA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01303146 | Oct 2008 → Mar 2010 | metachromatic leukodystrophy | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rhARSA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01303146 ↗ |
| Modality | Protein / enzyme biologic | “METAZYM is a recombinant human arylsulfatase A developed for an intravenous ERT” NCT01303146 ↗ |
| Route | Intravenous | “Patient will receive rhARSA (100 U/kg) intravenously” NCT01303146 ↗ |